Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation

Annals of Thoracic Surgery

Volumn 63, Issue 1, 1997, Pages 269-276

  Wan, Song ^a   Leclerc, Jean Louis ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8;

CARDIOPULMONARY BYPASS; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031028218     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00931-9     Document Type: Article

References (71)

1. Kirklin JW. Technical and scientific advances in cardiac surgery over the past 25 years. Ann Thorac Surg. 49:1990;26-31.
2. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass evidence for generation of C3a and C5a anaphylatoxins . N Engl J Med. 304:1981;497-503.
3. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 86:1983;845-857.
4. Tennenberg SD, Clardy CW, Bailey WW, Solomkin JS. Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg. 50:1990;597-601.
5. Bando K, Pillai R, Cameron DE, et al. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 99:1990;873-877.
6. Jansen NJG, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CRH. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg. 54:1992;744-748.
7. Jorens PG, de Jongh R, de Backer W, et al. Interleukin-8 production in patients undergoing cardiopulmonary bypass the influence of pretreatment with methylprednisolone . Am Rev Respir Dis. 148:1993;890-895.
8. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg. 53:1992;833-838.
9. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 106:1993;1008-1016.
10. Kalfin RE, Engelman RM, Rousou JA, et al. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation. 88(Suppl 2):1993;401-406.
11. Haeffner-Cavaillon N, Roussellier N, Ponzio O, et al. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 98:1989;1100-1106.
12. Jansen NJG, van Oeveren W, v.d. Broek L, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 102:1991;515-525.
13. Menasché P, Haydar S, Peynet J, et al. A potential mechanism of vasodilation after warm heart surgery the temperature-dependent release of cytokines . J Thorac Cardiovasc Surg. 107:1994;293-299.
14. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg. 105:1993;234-241.
15. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass participation of interleukin 8 and 6 in reperfusion injury . Can J Anaesth. 40:1993;1016-1021.
16. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 108:1994;626-635.
17. Tabardel Y, Duchateau J, Schmartz D, et al. Corticosteroids increase blood interleukin 10 levels during cardiopulmonary bypass in men. Surgery. 119:1996;76-80.
18. Wan S, Marchant A, DeSmet JM, et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 111:1996;469-477.
19. Seghaye MC, Duchateau J, Bruniaux J, et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg. 111:1996;545-553.
20. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation. 89:1994;2421-2432.
21. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
22. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 96:1995;1042-1052.
23. Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 112:1996;806-811.
24. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg. 56:1993;S92-6.
25. Ide H, Kakiuchi T, Furuta N, et al. The effect of cardiopulmonary bypass on T cells and their subpopulations. Ann Thorac Surg. 44:1987;277-282.
26. DePalma L, Yu M, McIntosh CL, Swain JA, Davey RJ. Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass the effect of blood transfusion . J Thorac Cardiovasc Surg. 101:1991;240-244.
27. Rocke DA, Gaffin SL, Wells MT, Koen Y, Brock-Utine JG. Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 93:1987;832-837.
28. Kharazmi A, Andersen LW, Baek L, Valerius NH, Laub M, Rasmussen JP. Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 98:1989;381-385.
29. Andersen LW, Baek L, Thomsen BS, Rasmussen JP. Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Anesth. 3:1989;544-549.
30. Te Velthuis H, Jansen PGM, Oudemans-van Straaten HM, Sturk A, Eijsman L, Wildevuur CRH. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. J Thorac Cardiovasc Surg. 110:1995;1663-1669.
31. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 318:1988;1481-1486.
32. Ohri SK, Bjarnason I, Pathi V, et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg. 55:1993;1080-1086.
33. Riddington DW, Venkatesh B, Boivin CM, et al. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA. 275:1996;1007-1012.
34. Dauber IM, Parsons PE, Welsh CH, et al. Peripheral bypass-induced pulmonary and coronary vascular injury association with increased levels of tumor necrosis factor . Circulation. 88:1993;726-735.
35. Ivey CL, Williams FM, Collins PD, Jose PJ, Williams TJ. Neutrophil chemoattractants generated in two phases during reperfusion of ischmic myocardium in the rabbit evidence for a role for C5a and interleukin-8 . J Clin Invest. 95:1995;2720-2728.
36. Kukielka GL, Smith CW, LaRosa GJ, et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest. 95:1995;89-103.
37. Neumann F-J, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 92:1995;748-755.
38. Lindal S, Gunnes S, Lund I, Straume BK, Jørgensen L, Sørlie D. Myocardial and microvascular injury following coronary surgery and its attenuation by mode of reperfusion. Eur J Cardiothorac Surg. 9:1995;83-89.
39. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 85:1990;1936-1943.
40. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium potential role in postreperfusion inflammatory injury . Circulation. 92:1995;1866-1875.
41. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 108:1994;636-641.
42. Gérard C, Bruyns C, Marchant A, et al. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 177:1993;547-550.
43. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 147:1991;3815-3822.
44. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery contrasting response between patients and isolated CPB circuits . Br J Anaesth. 75:1995;724-733.
45. Van der Poll T, Jansen J, Levi M, ten Cate H, ten Cate JW, van Deventer SJH. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med. 180:1994;1985-1988.
46. Oz MC, Liao H, Naka Y, et al. Ischemia-induced interleukin-8 release after human heart transplantation a potential role for endothelial cells . Circulation. 92(Suppl 2):1995;428-432.
47. Burns SA, Newburger JW, Xiao M, Mayer JE Jr, Walsh AZ, Neufeld EJ. Induction of interleukin-8 messenger RNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Circulation. 92(Suppl 2):1995;315-321.
48. Le Moine O, Marchant A, Durand F, et al. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology. 20:1994;889-892.
49. Wan S, LeClerc JL, Schmartz D, et al. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J (in press).
50. Wan S, DeSmet JM, Antoine M, Goldman M, Vincent JL, LeClerc JL. Steroid administration in heart and heart-lung transplantation is the timing adequate? Ann Thorac Surg. 61:1996;674-678.
51. Lichtenstein SV, Abel JG, Panos A, Slutsky AS, Salerno TA. Warm heart surgery experience with long cross-clamp times . Ann Thorac Surg. 52:1991;1009-1013.
52. Christakis GT, Koch JP, Deemar KA, et al. A randomized study of the systemic effects of warm heart surgery. Ann Thorac Surg. 54:1992;449-459.
53. Menasché P, Peynet J, Haeffner-Cavaillon N, et al. Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass. Circulation. 92(Suppl 2):1995;334-340.
54. Christman JW, Holden EP, Blackwell TS. Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med. 23:1995;955-963.
55. Millar AB, Armstrong L, van der Linden J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg. 56:1993;1499-1502.
56. Steinberg BM, Grossi EA, Schwarz DS, et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg. 60:1995;525-529.
57. Francalancia NA, Aeba R, Yousem SA, Griffith BP, Marrone GC. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation evaluation of a heparin-coated bypass circuit . J Heart Lung Transplant. 13:1994;498-507.
58. Gu YJ, van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CRH. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 55:1993;917-922.
59. Jansen PGM, te Velthuis H, Huybregts RAJM, et al. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits. J Thorac Cardiovasc Surg. 110:1995;829-834.
60. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 110:1995;1658-1662.
61. Replogle RL, Gazzaniga AB, Gross RE. Use of corticosteroids during cardiopulmonary bypass possible lysosome stabilization . Circulation. 33(Suppl 1):1966;86-91.
62. Niazi Z, Flodin P, Joyce L, Smith J, Mauer H, Lillehei RC. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest. 76:1979;262-268.
63. Engelman RM, Rousou JA, Flack JE III, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg. 60:1995;801-804.
64. Stefano GB, Rodriguez M, Glass R, Cesares F, Hughes TK, Bilfinger TV. Hyperstimulation of leukocytes by plasma from cardiopulmonary bypass patients is diminished by morphine and IL-10 pretreatment. J Cardiovasc Surg. 36:1995;25-30.
65. Teoh KHT, Bradley CA, Gauldie J, Burrows H. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation. 92(Suppl 2):1995;347-353.
66. Sundaresan S, Alevy YG, Steward N, et al. Cytokine gene transcripts for tumor necrosis factor-α, interleukin-2, and interferon-γ in human pulmonary allografts. J Heart Lung Transplant. 14:1995;512-518.
67. Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-α and interferon-γ after ischemia reperfusion injury in the lung allograft. Transplantation. 58:1994;1158-1162.
68. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the TH1/TH2 paradigm in transplantation. Curr Opin Immunol. 6:1994;757-764.
69. Azzawi M, Hasleton PS, Grant SCD, Stewart JP, Hutchinson IV. Interleukin-10 in human heart transplantation an in situ hybridization study . J Heart Lung Transplant. 14:1995;519-528.
70. Levy AE, Alexander JW. Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion/cyclosporine. Transplantation. 60:1995;405-406.
71. + T cells in vitro. J Immunol. 156:1996;2406-2412.